Featured Research

from universities, journals, and other organizations

Organism Can Cause Blindness In Extended-Wear Contact Lens Users If Left Untreated

Date:
March 7, 2000
Source:
Indiana State University
Summary:
Scientists at Indiana State University are working with a common bacterium that can quickly infect and cause blindness in extended-wear contact lens users. Worse than that-- many popular cleaning solutions aren't strong enough to fight it.

TERRE HAUTE, Ind. -- Scientists at Indiana State University are working with a common bacterium that can quickly infect and cause blindness in extended-wear contact lens users. Worse than that-- many popular cleaning solutions aren't strong enough to fight it.

More than 33 million people in the United States wear contact lenses, according to 1998 figures from the Vision Council of America. Of those, more than 83 percent use soft (including extended wear) contacts.

It is this population of contact lens wearers that is at risk of coming in contact with the organism Pseudomonas aeruginosa. This common bacterium can cause blindness within 36 hours in cases where the individual already has corneal abrasions or other eye injuries.

"The organism has been observed to initiate an infection of the cornea rather quickly," said Thomas Tsai, an optician and a senior life sciences and chemistry major at ISU. "It can double in number in less than an hour (from 1,000 to 2,000 cells), cause vision impairment within a few hours and total blindness within 36 hours when left untreated."

Tsai and Dr. Kathleen Dannelly, assistant professor of life sciences, are currently testing the bacteria on a model contact lens and have noticed the organism's ability to burrow into the wall of a lens, making it harder to kill with recommended cleaning solutions. As a result, they are looking into the possibility of a vaccine to prevent infection from ever occurring.

"Eye infections due to this strain of Pseudomonas were very rare before contact lenses became popular," Tsai explained. "The use of extended wear lenses, in particular, has caused it to become even more common."

The scientists also recently discovered that different lens solutions adhere to glass and different types of plastics commonly used in the manufacturing of contact lens cases. This, too, can interfere with a solution's ability to function at optimum levels, according to Tsai.

Tsai and Dannelly have been studying the effects of five contact lens solutions against two strains of Pseudomonas aeruginosa. Included in the testing were solutions by leading manufacturers, including Bausch and Lomb's new ReNu formula, Alcon's Opti-Free Enhanced, Original Opti-Free and Opti-One and Allergan's Complete.

Current Food and Drug Administration (FDA) guidelines require that contact lens solutions kill bacteria three times over in order to be deemed effective.

"The FDA uses a common and weaker form of this bacteria (found in soil) to test their solutions," explained Tsai. "We are using samples actually taken from patients who have gone blind as a result of this bacteria."

Dannelly and Tsai first tested the solutions' effects on the Pseudomonas sample in a dish, without applying the organism to an actual contact lens.

The ReNu formula (Bausch and Lomb) was found not to have much effect on the Pseudomonas even after eight hours in the solution; however, Alcon's Opti-Free Enhanced significantly reduced the number of organisms on contact.

"I would like to see doctors and opticians explain the cleaning regimen better. Patients also should clean their lenses thoroughly and contact their doctor as soon as they notice any severe irritation or redness. But, most importantly, people should never sleep with contact lenses in," Tsai said.

Tsai said he became interested in studying Pseudomonas infections with contact lens use as an optician at Wal-Mart. Dannelly, Tsai's co-investigator, was already studying Pseudomonas and its effects on the lacrimal gland (which causes tears), so it seemed a perfect fit to join the two areas of interest together, Tsai explained.

Tsai and Dannelly are working to secure grants through Wal-Mart and the National Institutes of Health to support their research.


Story Source:

The above story is based on materials provided by Indiana State University. Note: Materials may be edited for content and length.


Cite This Page:

Indiana State University. "Organism Can Cause Blindness In Extended-Wear Contact Lens Users If Left Untreated." ScienceDaily. ScienceDaily, 7 March 2000. <www.sciencedaily.com/releases/2000/03/000307090602.htm>.
Indiana State University. (2000, March 7). Organism Can Cause Blindness In Extended-Wear Contact Lens Users If Left Untreated. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/03/000307090602.htm
Indiana State University. "Organism Can Cause Blindness In Extended-Wear Contact Lens Users If Left Untreated." ScienceDaily. www.sciencedaily.com/releases/2000/03/000307090602.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins